Alzheimer’s disease progresses in stages. In stage 1, there are no symptoms, but imaging scans may show brain changes. By stage 5, the effect on a person’s mental and physical health can be ...
Alzheimer's disease (AD) remains one of the most challenging and prevalent neurodegenerative disorders, affecting millions of individuals worldwide. In a new study published in Developmental Cell ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Images provided by A. Mello, et al. A case report showed ...
Some people diagnosed with schizophrenia might instead be suffering from a rare visual condition that can cause other people's faces to appear "demonic," a new study argues. The condition, called ...
More than 6 million Americans have Alzheimer’s disease, the most common cause of dementia. There’s no cure, but Leqembi ...
Scientists insist that early diagnosis of dementia – by watching out for subtle symptoms – is key Credit: E+ It’s well known that memory loss and confusion are one of the early signs and ...
A major Alzheimer's breakthrough may have been made as new vaccine is being trialled which could 'transform' lives, scientists have said. People who have the early stages of the condition could be ...
At the beginning of March, the FDA delayed approval of another Alzheimer’s drug, an anti-amyloid called donanemab. Credit: Shutterstock In the past few years pharmaceutical companies have developed a ...
Familial Alzheimer's disease can be transferred via bone marrow transplant, researchers show March 28 in the journal Stem Cell Reports.When the team transplanted bone marrow stem cells from mice ...
Researchers have discovered that an FDA-approved epilepsy drug can prevent or slow the growth of NF1-linked optic gliomas in mice, laying the groundwork for a clinical trial. A drug used to treat ...
In this model of heritable Alzheimer's disease, mice usually begin developing plaques at nine to 10 months of age, and behavioral signs of cognitive decline begin to appear at 11 to 12 months of age.
A revolutionary jab, which is designed to remove toxic proteins from the brain before they cause the damage leading to the most common form of dementia, is undergoing trials on patients in the ...